PerkinElmer took part as an exhibitor in the Newborn Screening and Genetic Testing Symposium, held 10–13 September in New Orleans, Louisiana, USA. The symposium, sponsored by the Association of Public Health Laboratories, is a major global event for companies, organizations and advocacy groups involved with newborn screening.
We took the chance to showcase our new tandem mass spectrometry (MSMS) solutions designed to provide high throughput routine quantitation to laboratories.
The symposium addressed newborn screening, genetic testing and policy issues important to global public health. Topics included laboratory updates, molecular advances, candidate conditions, clinical outcomes, short and long-term follow-up and quality control.
As the global leader in newborn screening, PerkinElmer currently serves customers in more than 100 countries worldwide. Its customers have screened more than 560 million babies throughout the world for life-threatening diseases.